Toxicology of Kalopanax pictus extract and hematological effect of the isolated anti-rheumatoidal kalopanaxsaponin A on the Freunds complete adjuvant reagent-treated rat

被引:11
作者
Choi, J
Huh, K
Kim, SH
Lee, KT
Kwon, SH
Park, HJ [1 ]
机构
[1] Sangji Univ, Div Appl Plant Sci, Wonju 220702, South Korea
[2] Kyungsung Univ, Coll Pharm, Pusan 608736, South Korea
[3] Korea Food & Drug Adm, Seoul 12270, South Korea
[4] Dong A Univ, Dept Food Sci & Nutr, Pusan 604714, South Korea
[5] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea
关键词
Kalopanax pictus; kalopanaxsaponin A; Freunds complete adjuvant; toxicity; hematology; lipid metabolism;
D O I
10.1007/BF02976479
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have reported that kalopanaxsaponin A (KPS-A) isolated from Kalopanax pictus have anti-rheumatoidal activity in the rat treated with Freunds complete adjuvant (FCA) reagent. In addition, it has been also reported that KPS-A is a potent antioxidant in the rheumatoidal rat. This research was undertaken to examine whether the saponins of KPS-A and -I could adjust the abnormal lipid metabolisms and hematological changes in immunological diseases. KPS-A significantly inhibited the increases in both triglycerides and total proteins in addition to the decrease in total cholesterol induced by FCA reagent treatment KPS-A treatment decreased the number of leucocytes elevated by FCA reagent treatment. Excess dose of the methanol extract produced no severe toxicity on the body weight, wet organ weights and hepatic functions. Since LD50 value of K. pictus methanol extract was shown to be 4,033 mg/kg, it could be estimated to be a safe agent for anti-rheumatoidal herbal medicines.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 25 条
  • [1] CYTOCHEMICAL STUDIES OF LIPID-METABOLISM - IMMUNOGOLD PROBES FOR LIPOPROTEIN-LIPASE AND CHOLESTEROL
    BLANCHETTEMACKIE, EJ
    DWYER, NK
    AMENDE, LA
    [J]. AMERICAN JOURNAL OF ANATOMY, 1989, 185 (2-3): : 255 - 263
  • [2] CHOI J, 2000, 49 ANN CONV PHARM SO, P236
  • [3] CHOI J, 2000, 49 ANN CONV PHARM SO, P235
  • [4] CHOI JW, 2000, 49 ANN CONV PHARM SO, P188
  • [5] Ezeamuzie I C, 1992, Afr J Med Med Sci, V21, P23
  • [6] FRANCO JA, 1971, AM J CLIN PATHOL, V56, P538
  • [7] GREVER MR, 1980, BLOOD, V56, P284
  • [8] JU WK, 1993, LAB PHARM TOXICOLOGY, P53
  • [9] Growth inhibitory activities of kalopanaxsaponins A and I against human pathogenic fungi
    Kim, DW
    Bang, KH
    Rhee, YH
    Lee, KT
    Park, HJ
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 1998, 21 (06) : 688 - 691
  • [10] KIM JC, 1984, SUMMARY CLIN TEST ME, P242